The estimated Net Worth of Jason Bradley Md Terrell is at least $649 mil dollars as of 6 June 2022. Jason Terrell owns over 14,949 units of VolitionRX Ltd stock worth over $8,598 and over the last 9 years he sold VNRX stock worth over $204,374. In addition, he makes $436,135 as Chief Medical Officer and Head of US Operations at VolitionRX Ltd.
Sign up
Jason Terrell VNRX stock SEC Form 4 insiders trading
Jason has made over 8 trades of the VolitionRX Ltd stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 14,949 units of VNRX stock worth $36,924 on 6 June 2022.
The largest trade he's ever made was exercising 25,000 units of VolitionRX Ltd stock on 15 September 2020 worth over $61,750. On average, Jason trades about 4,581 units every 28 days since 2016. As of 6 June 2022 he still owns at least 12,300 units of VolitionRX Ltd stock.
You can see the complete history of Jason Terrell stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Jason Terrell biography
Dr. Jason Bradley Terrell M.D. serves as Chief Medical Officer and Head of US Operations of the Company. Effective January 1, 2016, Dr. Terrell was appointed to the position of Chief Medical Officer and Head of U.S. Operations on a full-time basis, having previously served in a part-time capacity in such position since March 2013. On February 3, 2017, Dr. Terrell was appointed Director and Chief Executive Officer of Volition America, and was additionally appointed a Manager and Vice President of Volition Vet on May 28, 2019 and August 7, 2019, respectively. Since February 2017, Dr. Terrell has also concurrently served as both a director and Chief Medical Diagnostics Officer of Generex Biotechnology Corporation (OTCMKTS: GNBT), a publicly-held biopharmaceutical company focused on developing or acquiring technologies that help pharmaceutical companies discover and develop medicines, and additionally as the non-executive chairman of the board of directors of Kiromic BioPharma, Inc. (a private company). Between January 2013 and October 2015, Dr. Terrell served on the board of directors of CDEX Inc., a publicly-held company developing drug validation technology, and between January 2012 and October 2015, as Medical Director of CDEX Inc. In addition, over the last six years, Dr. Terrell has built and sold multiple private diagnostic laboratories and currently serves as a National Franchise Corporate Medical Director for Any Lab Test Now, giving him oversight of over 70 franchises in 14 states. Dr. Terrell is a Texas-based doctor and earned a B.S. in Biochemistry from Hardin-Simmons University, where he graduated Summa Cum Laude, receiving the Holland Medal of Honor as the top graduate in the School of Science and Mathematics. He then attended the University of Texas at Houston Medical School and affiliate MD Anderson Cancer Center to become Doctor of Medicine. He undertook his General Medicine Internship, and Anatomic and Clinical Pathology Residency at Texas Tech University Health Sciences Center. In February 2014, Dr
What is the salary of Jason Terrell?
As the Chief Medical Officer and Head of US Operations of VolitionRX Ltd, the total compensation of Jason Terrell at VolitionRX Ltd is $436,135. There are 2 executives at VolitionRX Ltd getting paid more, with Cameron Reynolds having the highest compensation of $517,691.
How old is Jason Terrell?
Jason Terrell is 39, he's been the Chief Medical Officer and Head of US Operations of VolitionRX Ltd since 2016. There are 21 older and no younger executives at VolitionRX Ltd. The oldest executive at VolitionRX Ltd is Dr. Martin Charles Faulkes Ph.D., 77, who is the Exec. Chairman.
What's Jason Terrell's mailing address?
Jason's mailing address filed with the SEC is 1489 WEST WARM SPRINGS ROAD, SUITE 110, HENDERSON, NV, 89014.
Insiders trading at VolitionRX Ltd
Over the last 12 years, insiders at VolitionRX Ltd have traded over $775,239 worth of VolitionRX Ltd stock and bought 1,908,474 units worth $44,487,770,972 . The most active insiders traders include Guy Archibald Innes, Cameron John Reynolds y Martin Charles Faulkes. On average, VolitionRX Ltd executives and independent directors trade stock every 43 days with the average trade being worth of $27,899. The most recent stock trade was executed by Guy Archibald Innes on 20 August 2024, trading 150,000 units of VNRX stock currently worth $100,500.
What does VolitionRX Ltd do?
volitionrx is a life sciences company whose goal is to make its non-invasive blood tests for cancer as common and simple to use as existing diabetic and cholesterol tests on similar formats. volitionrx’s development activities are currently centered in belgium with a focus on bringing its revolutionary diagnostic products to market first in europe, then the u.s. and worldwide. you can find more information about volitionrx at our website at www.volitionrx.com, on twitter at www.twitter.com/volitionrx, linkedin at http://www.linkedin.com/company/volitionrx or facebook at www.facebook.com/volitionrx.
What does VolitionRX Ltd's logo look like?
Complete history of Jason Terrell stock trades at VolitionRX Ltd
VolitionRX Ltd executives and stock owners
VolitionRX Ltd executives and other stock owners filed with the SEC include:
-
Cameron Reynolds,
President, Chief Executive Officer, Director -
Cameron Reynolds MBA,
Founder, Group CEO, Pres & Director -
Jason Terrell,
Chief Medical Officer and Head of US Operations -
Dr. Jason Bradley Terrell,
Chief Medical Officer & Head of U.S. Operations -
David Vanston,
Chief Financial Officer, Treasurer -
Jacob Micallef,
Chief Scientific Officer -
Martin Faulkes,
Executive Chairman of the Board -
Rodney Rootsaert,
Corporate Secretary -
Dr. Martin Charles Faulkes Ph.D.,
Exec. Chairman -
Dr. Jacob Vincent Micallef,
Chief Scientific Officer -
Dr. Salvatore Thomas Butera,
Chief Exec. Officer of Volition Veterinary Diagnostics Devel. LLC -
Scott Powell,
IR Contact Officer -
Guy Innes,
Independent Director -
Edward Futcher,
Independent Director -
Alan Colman,
Independent Director -
Phillip Barnes,
Independent Director -
Gaetan Michel,
Chief Executive Officer of Belgian Volition -
Jasmine Kway,
Chief Executive Officer of Singapore Volition -
Nick Plummer,
Group Gen. Counsel -
Scott Powell Ph.D.,
Exec. VP of Investor Relations & CFO of Volition America Inc -
Dr. Mark Eccleston M.B.A., Ph.D.,
Chief Technology Officer -
Dr. Gaetan Michel Ph.D.,
Chief Operating Officer -
Terig Hughes,
Group CFO & Treasurer -
Corp Ltd Cotterford Co Ltd ...,
-
Richard Brudnick,
-
Habib Skaff,
Director -
David Matthew Kratochvil,
Chief Financial Officer -
Rodney Gerard Concord Inter...,
Secretary -
Nicholas Plummer,
GC - Volition Diagnostics -
Ann Louise Batchelor,
Group Chief Marketing Officer -
Kim Nguyen,
-
Terig Hughes,
Chief Financial Officer -
Mickie Henshall,
-
Gael Forterre,
Chief Commercial Officer -
Corp Ltd Hever Investments ...,
-
Salvatore Thomas Butera,
CEO - Volition Veterinary